oxazolidin-2-one has been researched along with micafungin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cappelletty, D; Jacobs, D | 1 |
| Kamoshita, F; Karaushi, H; Mitsutake, K; Miyawaki, Y; Seki, M; Watanabe, N | 1 |
2 other study(ies) available for oxazolidin-2-one and micafungin
| Article | Year |
|---|---|
Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team.
Topics: Acetamides; Anti-Infective Agents; Antifungal Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Echinocandins; Guideline Adherence; Humans; Imipenem; Length of Stay; Linezolid; Lipopeptides; Medication Errors; Medication Therapy Management; Micafungin; Ohio; Oxazolidinones; Patient Care Team; Pharmacy Service, Hospital; Retrospective Studies; Workforce | 2013 |
A Mycobacterium tuberculosis-Infected Patient Who Could Not Tolerate Oral Intake Successfully Treated Using an Intravenous Tedizolid-Containing Regimen.
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Cutaneous Fistula; Ethambutol; Humans; Isoniazid; Levofloxacin; Linezolid; Male; Meropenem; Micafungin; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Rifampin; Streptomycin; Teicoplanin; Tetrazoles; Tuberculosis | 2022 |